SCHEMBL27487296

SCHEMBL27487296

CC(CCC(C)C(=O)O)Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
ALPI P09923 1/20 0.50
PKM P14618 1/20 0.50
PTGS1 P23219 1/20 0.50
XIAP P98170 1/20 0.50
SLC7A5 Q01650 1/20 0.50
CPA3 P15088 3/20 0.49
HPGD P15428 1/20 0.49
CYP3A4 P08684 2/20 0.47
TSHR P16473 2/20 0.47
CPA1 P15085 2/20 0.47
FOLH1 Q04609 1/20 0.47
CPB1 P15086 1/20 0.47
CPB2 Q96IY4 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TBXAS1 P24557 1/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17171334 0.85 CYP1A2 (0.53) CYP1A2NPC1RAB9AALPIPKM
SCHEMBL17171335 0.85 CYP1A2 (0.53) CYP1A2NPC1RAB9AALPIPKM
SCHEMBL11210664 0.85 CYP1A2 (0.53) CYP1A2NPC1RAB9AALPIPKM
SCHEMBL27488752 0.84 PPARG (0.49) TSHR
SCHEMBL27506589 0.84 TRPA1 (0.47) PTGS1HPGDCYP3A4TSHRCPA1
SCHEMBL265577 0.84 CYP1A2 (0.61) CYP1A2NPC1RAB9AALPIPKM
SCHEMBL65930 0.84 CYP1A2 (0.61) CYP1A2NPC1RAB9AALPIPKM
SCHEMBL265135 0.84 CYP1A2 (0.61) CYP1A2NPC1RAB9AALPIPKM
SCHEMBL12494703 0.83 CYP1A2 (0.68) CYP1A2CPA3CPA1FOLH1CPB1
SCHEMBL12494839 0.83 CYP1A2 (0.68) CYP1A2CPA3CPA1FOLH1CPB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1355784-A Mono-and disubstituted 3-propyl-gamma-aminobutyric acids WARNER LAMBERT CO (US) 2002-06-26 CN claimed
CN-101862317-A The pregabalin derivant that is used for the treatment of fibromyalgia and other disease WARNER LAMBERT CO 2010-10-20 CN disclosed
CN-101283995-A Different pharmaceutical uses alpha2delta ligands WARNER LAMBERT CO (US) 2008-10-15 CN disclosed
CN-1310872-C Mono- and disubstituted 3-propyl gamma-aminobutyric acids WARNER LAMBERT CO (US) 2007-04-18 CN disclosed
CN-1878546-A Combination comprising an alpha-2 delta ligand and an SSRI and/or SNRI for the treatment of depression and anxiety WARNER LAMBERT CO (US) 2006-12-13 CN disclosed
CN-1726015-A Alpha 2 delta ligands for different pharmaceutical uses WARNER LAMBERT CO (US) 2006-01-25 CN disclosed
CN-1726023-A Pregabalin derivatives for the treatment of fibromyalgia and other diseases WARNER LAMBERT CO (US) 2006-01-25 CN disclosed
CN-1678298-A Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder WARNER LAMBERT CO (US) 2005-10-05 CN disclosed
CN-1660779-A Mono- and disubstituted 3-propyl gamma-aminobutyric acids WARNER LAMBERT CO (US) 2005-08-31 CN disclosed
CN-1625393-A Alpha 2 delta ligands to treat tinnitus WARNER LAMBERT CO (US) 2005-06-08 CN disclosed
CN-1196671-C Mono-and disubstituted 3-propyl-gamma-aminobutyric acids WARNER LAMBERT CO (US) 2005-04-13 CN disclosed
CN-1355784-A Mono-and disubstituted 3-propyl-gamma-aminobutyric acids WARNER LAMBERT CO (US) 2002-06-26 CN disclosed